Skip to main content

Genome-wide CRISPR base-editing screening defines drug response networks in Leishmania

Arias del Angel J, Link F, Herrmann May N, Ekici I, Wawra K, Schwind S, Zorn S, Haggarty J, Weidt SK, Ritchie R, Barrett MP, van Zandbergen G, Beneke T
bioRxiv 2025.06.16.659792 (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
236783LmexBE_v1A genome-wide loss-of-function CRISPR base editing library designed to introduce STOP codons within the first 50% of coding sequences in the genome of Leishmania mexicana.

Antibodies from Article